Original site: www.cdc.gov/vaccines/vpd/dengue/hcp/recommendations.html | RestoredCDC.org is an independent project, not affiliated with CDC or any federal entity. Visit CDC.gov for free official information. Due to archival on January 6, 2025, recent outbreak data is unavailable. Videos are not restored. Access data.restoredcdc.org for restored data. Use of this site implies acceptance of this disclaimer.

[More]
About Us Report Bug

RestoredCDC.org Comparison

Removed: Line removed from cdc.gov. Specific word removals are highlighted.
Added: Line added to cdc.gov. Specific word additions are highlighted.
Injected: Line or disclaimer added by RestoredCDC.org.
Unchanged: Line unchanged.
Original site: www.cdc.gov/vaccines/vpd/dengue/hcp/recommendations.html | RestoredCDC.org is an independent project, not affiliated with CDC or any federal entity. Visit CDC.gov for free official information. Due to archival on January 6, 2025, recent outbreak data is unavailable. Videos are not restored. Access data.restoredcdc.org for restored data. Use of this site implies acceptance of this disclaimer.
[More]
About Us Report Bug Compare Content
Skip directly to site content Skip directly to search
Español | Other Languages
Here's how you know
An official website of the United States government Here's how you know
Vaccines & Immunizations
Vaccines & Immunizations
Centers for Disease Control and Prevention. CDC twenty four seven. Saving Lives, Protecting People Vaccines & Immunizations
Search
Search Menu Navigation Menu
Submit
Vaccines & Immunizations
* Vaccines by Disease
+ BACK
Vaccines by Disease
+ COVID-19
+ Dengue
o BACK
Dengue
o BACK
Vaccines by Disease Dengue
o Dengue Vaccine Recommendations
o Vaccines & Immunizations Home
+ Diphtheria
+ Diphtheria, Tetanus, and Pertussis
+ Hepatitis A
+ Hepatitis B
+ Hib (Haemophilus influenzae type b)
+ HPV (Human Papillomavirus)
+ Influenza (Flu)
+ Measles, Mumps, and Rubella
+ Meningococcal
+ Mpox
+ Pneumococcal
+ Polio (Poliomyelitis)
+ Rotavirus
+ RSV (Respiratory Syncytial Virus)
+ Shingles (Herpes Zoster)
+ Varicella (Chickenpox)
+ Adenovirus
+ Anthrax
+ Chikungunya
+ Cholera
+ Ebola
+ Japanese Encephalitis (JE)
+ Rabies
+ Smallpox
+ Tuberculosis
+ Typhoid Fever
+ Yellow Fever
+ Vaccines & Immunizations Home
* Vaccines & Immunizations Home
Vaccines & Immunizations
Vaccines & Immunizations Home
Dengue Vaccine Recommendations
Dengue Vaccine Recommendations
Print
Related Pages
Sanofi-Pasteur will stop manufacturing its dengue vaccine for children. The manufacturer is discontinuing the vaccine citing a lack of demand in the global market to continue production of this vaccine. CDC, in collaboration with the Puerto Rico Department of Health, will continue alerting health professionals about the discontinuation of Dengvaxia and the use of this vaccine as recommended by the Advisory Committee on Immunization Practices (ACIP). Dengvaxia is safe and effective when administered as recommended. There are two other dengue vaccines either approved or in late stages of development. However, they are not currently available in the United States. People can continue to protect themselves and their families from dengue by preventing mosquito bites and controlling mosquitoes in and around their homes.
Below are summaries of recommendations from CDC’s Advisory Committee on Immunization Practices (ACIP). For the full text of the recommendations, see Dengue Vaccine: Recommendations of the Advisory Committee on Immunization Practices, United States, 2021.
Dengue vaccine is recommended for adolescents who are:
* 9–16 years old
* Live in areas where dengue occurs frequently or continuously including:
+ American Samoa
+ Puerto Rico
+ U.S. Virgin Islands
+ Federated States of Micronesia
+ Republic of Marshall Islands
+ Republic of Palau
* Have laboratory-confirmed evidence of previous dengue infection including:
+ Positive dengue RT-PCR test result, or
+ Positive dengue NS1 antigen test result, or
+ Positive results on a pre-vaccination screening dengue virus IgG testing process meeting specific performance standards
+ For more information, see Laboratory Testing Requirements for Vaccination with Dengvaxia Dengue Vaccine.
Contraindications and Precautions
Do not administer dengue vaccines to
* A person who lacks laboratory evidence of previous dengue infection
* A person who has ever had a severe allergic reaction (e.g., anaphylaxis) after a previous dose of this vaccine
* A person who has a severe allergy to any vaccine component (see the Dengvaxia package insert)
* A person with severe immunodeficiency or immunosuppression due to underlying disease or therapy, including persons with symptomatic HIV infection or CD4+ T-lymphocyte count of <200/mm3.
* A person who lacks laboratory evidence of a previous dengue infection
Healthcare providers should weigh the risks of vaccination against the risk for dengue for the following populations:
* Pregnant people
* Pregnant women
* Breastfeeding people
* Breastfeeding women
* Persons with HIV infection
* Persons with moderate or severe acute illness with or without fever
Top of Page
Last Reviewed: June 28, 2024
Source: National Center for Immunization and Respiratory Diseases
* Facebook
* Twitter
* LinkedIn
* Syndicate
home Vaccines & Immunizations Home
* Vaccines by Disease plus icon
+ COVID-19
+ Dengue
o Dengue Vaccine Recommendations
+ Diphtheria
+ Diphtheria, Tetanus, and Pertussis
+ Hepatitis A
+ Hepatitis B
+ Hib (Haemophilus influenzae type b)
+ HPV (Human Papillomavirus)
+ Influenza (Flu)
+ Measles, Mumps, and Rubella
+ Meningococcal
+ Mpox
+ Pneumococcal
+ Polio (Poliomyelitis)
+ Rotavirus
+ RSV (Respiratory Syncytial Virus)
+ Shingles (Herpes Zoster)
+ Varicella (Chickenpox)
+ Adenovirus
+ Anthrax
+ Chikungunya
+ Cholera
+ Ebola
+ Japanese Encephalitis (JE)
+ Rabies
+ Smallpox
+ Tuberculosis
+ Typhoid Fever
+ Yellow Fever
* About CDC
* Contact Us
* 800-232-4636
Facebook Twitter Instagram LinkedIn Youtube Pinterest Snapchat
Facebook Twitter Instagram LinkedIn Youtube Pinterest Snapchat RSS
* CONTACT CDC
Contact Us
Call 800-232-4636
Email Us
* ABOUT CDC
+ About CDC
+ Jobs
+ Funding
* POLICIES
+ Accessibility
+ External Links
+ Privacy
+ Policies
+ Web Policies
+ No Fear Act
+ FOIA
+ OIG
+ No Fear Act
+ Nondiscrimination
+ Vulnerability Disclosure Policy
+ CDC Archive
+ Public Health Publications
+ HHS.gov
+ USA.gov
* CONNECT WITH US
+ Facebook
+ Twitter
+ Instagram
+ LinkedIn
+ Youtube
+ Pinterest
+ Snapchat
+ Email
* LANGUAGES
+ Español
+ 繁體中文
+ Tiếng Việt
+ 한국어
+ Tagalog
+ Русский
+ العربية
+ Kreyòl Ayisyen
+ Français
+ Polski
+ Português
+ Italiano
+ Deutsch
+ 日本語
+ فارسی
+ English
* U.S. Department of Health & Human Services
* Accessibility
* External Links
* Privacy
* Policies
* Web Policies
* FOIA
* OIG
* No Fear Act
* FOIA
* Nondiscrimination
* OIG
* Vulnerability Disclosure Policy
* CDC Archive
* Public Health Publications
* HHS.gov
* USA.gov
Content Credential
×
This image was edited or created using GenAI (generative artificial intelligence).
Our experts review all images in an effort to ensure accuracy and quality before use.
Learn more about CDC's usage of GenAI.
Note: Comparison ignores leading/trailing whitespace and certain script/tracking codes. Word-level highlighting (optional above) only applies to changed lines.